+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antivenoms: Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309401

Global Antivenoms Market to Reach $2.3 Billion by 2030

The global market for Antivenoms estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2022-2030. Snakes, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Scorpions segment is readjusted to a revised 6.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $339.3 Million, While China is Forecast to Grow at 10.9% CAGR

The Antivenoms market in the U.S. is estimated at US$339.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$545 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Select Competitors (Total 46 Featured) -

  • Boehringer Ingelheim International GmbH
  • BTG PLC
  • CSL Ltd.
  • Merck & Co., Inc.
  • MicroPharm Ltd.
  • Pfizer, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Antivenoms - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Antivenoms Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Antivenoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 3: World Historic Review for Antivenoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 4: World 16-Year Perspective for Antivenoms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Snakes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World Historic Review for Snakes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 7: World 16-Year Perspective for Snakes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Scorpions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 9: World Historic Review for Scorpions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 10: World 16-Year Perspective for Scorpions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Spiders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 12: World Historic Review for Spiders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 13: World 16-Year Perspective for Spiders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Species by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Species by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: World 16-Year Perspective for Other Species by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Polyvalent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 18: World Historic Review for Polyvalent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: World 16-Year Perspective for Polyvalent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Monovalent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 21: World Historic Review for Monovalent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: World 16-Year Perspective for Monovalent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Other Anti-Venom Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 24: World Historic Review for Other Anti-Venom Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: World 16-Year Perspective for Other Anti-Venom Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: USA 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: USA Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: USA 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: Canada 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 35: Canada Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Canada 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
JAPAN
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Japan 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 41: Japan Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: Japan 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
CHINA
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: China 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 47: China Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: China Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: China 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
EUROPE
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Antivenoms by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Antivenoms by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for Antivenoms by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 58: Europe 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
FRANCE
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 59: France Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 61: France 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: France Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 64: France 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
GERMANY
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 67: Germany 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 70: Germany 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 73: Italy 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 76: Italy 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 79: UK 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: UK Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 82: UK 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
SPAIN
  • Table 83: Spain Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 85: Spain 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 86: Spain Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Spain Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 88: Spain 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
RUSSIA
  • Table 89: Russia Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 91: Russia 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 92: Russia Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Russia Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 94: Russia 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Antivenoms by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Antivenoms by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Antivenoms by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Antivenoms by Species - Snakes, Scorpions, Spiders and Other Species Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Antivenoms by Species - Percentage Breakdown of Value Sales for Snakes, Scorpions, Spiders and Other Species for the Years 2014, 2023 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Antivenoms by Anti-Venom Type - Polyvalent, Monovalent and Other Anti-Venom Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 109: Asia-Pacific 16-Year Perspective for Antivenoms by Anti-Venom Type - Percentage Breakdown of Value Sales for Polyvalent, Monovalent and Other Anti-Venom Types for the Years 2014, 2023 & 2030
AUSTRALIA
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Antivenoms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boehringer Ingelheim International GmbH
  • BTG PLC
  • CSL Ltd.
  • Merck & Co., Inc.
  • MicroPharm Ltd.
  • Pfizer, Inc.

Table Information